Junyelt (Copper Gluconate, Manganese Gluconate, Potassium Iodide, Sodium Selenite, Zinc Gluconate)

• Junyelt is a trace element supplement used in clinical settings that require parenteral provision of essential micronutrients.
• Micronutrient deficiency: restores copper, manganese, iodine, selenium, and zinc levels in patients with documented deficiencies.
• Parenteral nutrition: supplies essential trace elements as part of total parenteral nutrition admixtures for patients unable to take oral nutrition.
• Pre‑operative preparation: optimizes trace element status before major surgery to support metabolic and immune function.

• The constituents of Junyelt act as essential cofactors for a variety of enzymatic reactions. Intravenous administration bypasses gastrointestinal absorption, delivering copper, manganese, iodine, selenium, and zinc directly into the bloodstream where they are incorporated into metalloenzymes, antioxidant selenoproteins, thyroid hormone synthesis pathways, and other cellular processes critical for oxidative defense, energy production, and immune competence. These trace elements support the activity of enzymes such as cytochrome c oxidase, superoxide dismutase, and deiodinases, thereby influencing metabolic and endocrine functions.

Junyelt may be associated with the following adverse reactions, which vary in frequency and severity.

Common Side Effects

• Injection site pain: mild discomfort at the infusion site.
• Transient metallic taste: brief metallic sensation in the mouth.
• Nausea: mild upset stomach following administration.
• Headache: mild to moderate headache occurring shortly after infusion.

Serious or Rare Side Effects

• Anaphylactic reaction: severe allergic response requiring immediate medical intervention.
• Copper or selenium toxicity: signs of excess such as abdominal pain, vomiting, or neurological symptoms.

When using Junyelt, clinicians should observe the following precautions to ensure safe administration.

• Baseline assessment: evaluate serum trace element levels before initiating therapy.
• Therapeutic monitoring: regularly measure copper, manganese, iodine, selenium, and zinc concentrations during treatment.
• Hypersensitivity: avoid in patients with known allergy to any component of the formulation.
• Organ impairment: use with caution in patients with severe renal or hepatic dysfunction.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Junyelt can interact with other medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• High‑dose copper supplements: may cause copper overload and toxicity.
• High‑dose selenium supplements: increase risk of selenosis.
• Iodine‑containing contrast agents: can alter thyroid function when combined.

Moderate Interactions (Monitor Closely)

• Anticoagulants: trace elements may affect platelet function and alter bleeding risk.
• Thyroid hormone therapy: iodine content may require adjustment of levothyroxine dose.
• Renal dialysis: procedure may remove administered trace elements, reducing efficacy.